首页> 外文OA文献 >Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV ‐1‐infected patients

【2h】

Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV ‐1‐infected patients

机译：双重疗法与未沸腾的atazanavir和拉米夫定作为病毒学抑制的艾滋病毒-1感染患者的维持治疗组合

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
F Rigo; G Cucchetto; M Lanzafame; S Nicolè; E Lattuada; E Concia; S Vento;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV HIV ‐1‐infected patients [J] . Rigo F, Cucchetto G, Lanzafame M, HIV medicine . 2017,第10期

机译：双重疗法与未煮沸的atazanavir和拉米夫定作为病毒学抑制的艾滋病毒HIV -1感染患者的维持治疗组合
2. Treatment simplification to atazanavir/ritonavir plus lamivudine versus maintenance of atazanavir/ritonavir plus two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) [J] . Di Giambenedetto Simona, Fabbiani Massimiliano, Roldan Eugenia Quiros, The Journal of Antimicrobial Chemotherapy . 2017,第4期

机译：Atazanavir / Ritonavir Plus Lamivudine与Atazanavir / ritonavir的verueus uperus upse的治疗简化为病毒学抑制的HIV-1感染患者两种NRTIS：随机试验的48周结果（阿特拉斯-M）
3. Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial [J] . Fabbiani Massimiliano, Gagliardini Roberta, Ciccarelli Nicoletta, The Journal of Antimicrobial Chemotherapy . 2018,第7期

机译：Atazanavir / Ritonavir用拉米夫定作为病毒学抑制的艾滋病毒感染患者的维护治疗：随机试验的96周结果
4. Predictability of Sustained Virological Response (SVR) in Patients with HCV/HIV Co-infection During Combination Therapy With Peginterferon Alfa-2A (40KD) (PEGASYS~R) Plus Ribavirin (COPEGUS~R) in the APRICOT Trial [C] . M. Rodriguez Torres, F.J. Torriani, E. Lissen International AIDS Conference . 2004

机译：HCV / HIV与Peginterferon Alfa-2a（40KD）（Pegasys〜R）加上利韦韦林（Copegus〜R）在杏试验期间HCV / HIV CONOMENT患者持续病毒学反应（SVR）的可预测性
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients [O] . Alicia Gutierrez-Valencia, Coral García, Pompeyo Viciana, 2012

机译：在HIV-1感染的患者中，通过病毒学抑制，简化用增强或未增强阿扎那韦加拉米夫定治疗的有效性没有差异
7. Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial [O] . Massimiliano Fabbiani, Roberta Gagliardini, Nicoletta Ciccarelli, 2018

机译：Atazanavir / Ritonavir用拉米夫定作为病毒学抑制艾滋病毒感染患者的维护治疗：随机试验的96周结果

Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV ‐1‐infected patients

著录项

引文网络

相似文献

相关主题

期刊订阅